Cargando…
Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
The reactivation of telomerase in cancer cells remains incompletely understood. The catalytic component of telomerase, hTERT, is thought to be the limiting component in cancer cells for the formation of active enzymes. hTERT gene expression is regulated at several levels including chromatin, DNA met...
Autores principales: | Ludlow, Andrew T., Slusher, Aaron L., Sayed, Mohammed E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562651/ https://www.ncbi.nlm.nih.gov/pubmed/31091669 http://dx.doi.org/10.3390/cancers11050666 |
Ejemplares similares
-
The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics
por: Slusher, Aaron L., et al.
Publicado: (2020) -
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity
por: Liu, Xuewen, et al.
Publicado: (2017) -
Dynamics of TERT regulation via alternative splicing in stem cells and cancer cells
por: Kim, Jeongjin J., et al.
Publicado: (2023) -
Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes
por: Plyasova, Anna A., et al.
Publicado: (2021) -
NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells
por: Sayed, Mohammed E., et al.
Publicado: (2018)